Orion Diagnostica QuikRead CRP Manual De Instrucciones página 6

FI 102642 B; EP 859664 B1; US 6,149,866; PL 183800; FI 101543 B; EP 946871 B1;
US 6,358,753; AU 732232; IL 130459.
1. Price CP, Calvin J, Walker SA, Trull A, Newman DJ, Gorman EG. Rapid and sensitive
automated light scattering immunoassay for serum C-reactive protein and the definition of
a reference range in healthy blood donors. Clin Chem Lab Med 1999, 37, 109–113.
2. van Leeuwen MA, van Rijswijk MH. Acute phase proteins in the monitoring of
inflammatory disorders. Baillière's Clinical Rheumatology 1994, 531–552.
3. Olaison L, Hogevik H, Alestig K. Fever C-reactive protein and other acute-phase reactants
during treatment of infective endocarditis. Arch Intern Med 1997, 157, 885–892.
4. Peltola H, Unkila-Kallio L, Kallio MJT. Simplified treatment of acute staphylococcal
osteomyelitis of childhood. Pediatrics, 1997, 99, 846–850.
5. Philip AGS, Mills PC. Use of C-reactive protein in minimizing antibiotic exposure:
Experience with infants initially admitted to a well-baby nursery. Pediatrics, 2000, 106, 1–5.
6. Pepys MB. The acute phase response and C-reactive protein. In: Warrell DA, Cox
TM, Firth JD, Benz EJ, editors. Oxford Textbook of Medicine, 4th ed. Oxford University
Press, 2003. Vol 2, p. 150–156.
7. Seamark DA, Backhouse SN, Powell R. Field-testing and validation in a primary care
setting of a point-of-care test for C-reactive protein. Ann Clin Biochem 2003;40:178–180.
8. Thomas L. C-reaktives Protein (CRP) [C-reactive protein (CRP). In German.]. In: Labor
und Diagnose, 4th ed. Marburg: Die Medizinische Verlagsgesellschaft; 1992. p. 780–790.
QuikRead is a registered trademark of Orion Diagnostica Oy.
®
QuikRead ist eingetragenes Warenzeichen von Orion Diagnostica Oy.
®
Orion Diagnostica Oy
Koivu-Mankkaan tie 6 B
P.O.Box 83, FI-02101 Espoo, Finland
Tel. +358 10 4261
Fax +358 10 426 2794
www.oriondiagnostica.com
www.quikread.com
Patents • Patente
References • Referenzen
3/2017